tirzepatide or semaglutide which is better vs for Weight Loss Tirzepatide GLP-1 medication may be

Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications

Based on these measurements, the size of dissolved nanoparticle samples were relatively stable even after six months, but aggregation or disintegration cannot be excluded due to the large PDI values

For most people with diabetes, an A1C level below 7% is considered good and indicates that blood sugar levels have been well controlled

Both options are administered as once-weekly injections that you can do at home after receiving instructions from our team

(PubMed) Yamanaka G, Suzuki S, Takeshita M, et al

The most common side effects reported are gastrointestinal in nature, including: Nausea Vomiting Diarrhea Constipation These side effects tend to be mild to moderate and typically decrease over time as your body adjusts to the medication